CVE:GSD Devonian Health Group (GSD) Stock Price, News & Analysis → They said crypto was dead. It went up 100X. (From InvestorPlace) (Ad) Free GSD Stock Alerts C$0.20 -0.01 (-2.44%) (As of 03/15/2024 05:43 PM ET) Add Compare Share Share Today's RangeC$0.20▼C$0.2550-Day RangeC$0.13▼C$0.2552-Week RangeC$0.11▼C$0.30Volume24,500 shsAverage Volume20,252 shsMarket CapitalizationC$29.35 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartStock AnalysisChart Get Devonian Health Group alerts: Email Address Ad Colonial MetalsCentral Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About Devonian Health GroupDevonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, completed Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, the company acquires drug and health product licenses; and distributes pharmaceutical products. Devonian Health Group Inc. was incorporated in 2015 and is headquartered in Québec, Canada.Read More GSD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GSD Stock News HeadlinesOctober 24, 2022 | finance.yahoo.comDevonian Health Group Inc. to Participate in Three Renmark’s Virtual Non-Deal Roadshow SeriesAugust 29, 2022 | finance.yahoo.comDevonian Announces Executive Changes, Grant of Stock Options and Settlement of Interests and Repayment of Principal Amount Owed to a Debenture HolderMarch 19, 2024 | Porter & Company (Ad)My next big prediction isn’t a predictionI believe this could change your life forever. I’m talking about transforming everything for you, financially. You see, a rare market anomaly has emerged that I believe is going to make some people very wealthy. Almost nobody in the mainstream media or Wall Street has connected the dots on what’s going on, but that ignorance won’t last for long. When they wake up to this situation, billions of dollars will flood in.May 28, 2022 | wsj.comDevonian Health Group Inc.May 27, 2022 | nz.finance.yahoo.comJack Ma’s Ant Ekes Out Profit Rise as Fintech Overhaul AdvancesMay 27, 2022 | yahoo.comImplantable Biomaterials Global Market Report 2022May 6, 2022 | news.yahoo.comRussia avoids default at the last moment as a clearinghouse processes its dollar bond paymentsMay 4, 2022 | investing.comDevonian Health Group Inc (GSD)March 19, 2024 | Porter & Company (Ad)My next big prediction isn’t a predictionI believe this could change your life forever. I’m talking about transforming everything for you, financially. You see, a rare market anomaly has emerged that I believe is going to make some people very wealthy. Almost nobody in the mainstream media or Wall Street has connected the dots on what’s going on, but that ignorance won’t last for long. When they wake up to this situation, billions of dollars will flood in.May 4, 2022 | finance.yahoo.comIs Devonian Health Group (CVE:GSD) Using Debt In A Risky Way?See More Headlines Receive GSD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Devonian Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/19/2024Next Earnings (Estimated)3/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:GSD CUSIPN/A CIKN/A Webwww.groupedevonian.com Phone450-937-6696FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-4,120,000.00 Net Margins-128.59% Pretax MarginN/A Return on Equity-28.06% Return on Assets-12.41% Debt Debt-to-Equity Ratio26.17 Current Ratio1.28 Quick Ratio7.82 Sales & Book Value Annual SalesC$3.21 million Price / Sales9.14 Cash FlowC$0.03 per share Price / Cash Flow6.10 Book ValueC$0.10 per share Price / Book2.00Miscellaneous Outstanding Shares146,730,000Free FloatN/AMarket CapC$29.35 million OptionableNot Optionable Beta1.59 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Luc D. Gregoire CA (Age 64)CPA, President, CEO & Director Ms. Colette Laurin C.A.CPA, Interim CFO, Corporate Secretary & Corporate ControllerDr. Andre P. Boulet Ph.D. (Age 65)Chief Scientific Officer & Director Comp: $644.63kKey CompetitorsCovalon TechnologiesCVE:COVAptose BiosciencesTSE:APSIBEX TechnologiesCVE:IBTAcasti PharmaCVE:ACSTAntibe TherapeuticsTSE:ATEView All Competitors GSD Stock Analysis - Frequently Asked Questions How have GSD shares performed in 2024? Devonian Health Group's stock was trading at C$0.15 at the start of the year. Since then, GSD shares have increased by 37.9% and is now trading at C$0.20. View the best growth stocks for 2024 here. When is Devonian Health Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 27th 2024. View our GSD earnings forecast. How do I buy shares of Devonian Health Group? Shares of GSD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:GSD) was last updated on 3/19/2024 by MarketBeat.com Staff From Our Partners8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe world’s greatest investmentPorter & CompanyBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Devonian Health Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.